| Callie Lamay, DPM | |
|
767 Boston Post Rd, Old Saybrook, CT 06475-2127 | |
| (860) 388-2641 | |
| (860) 395-2928 |
| Full Name | Callie Lamay |
|---|---|
| Gender | Female |
| Speciality | Podiatry |
| Experience | 34 Years |
| Location | 767 Boston Post Rd, Old Saybrook, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1467581769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000529 (Connecticut) | Primary |
| Provider Name | Saybrook Podiatry Associates, Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1669539615 PECOS PAC ID: 0244416618 Enrollment ID: O20110519000321 |
News Archive
Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern. Recombinant monoclonal antibody therapeutics (mAbs) represent the largest group of therapeutic proteins the analysis of the glycan pattern is therefore an essential part of the mAb characterization process.
A study by York University researcher Caroline Davis and her colleagues at the Centre for Addiction and Mental Health is the first to demonstrate that variants of the Oxytocin Receptor gene contribute to why some of us overeat or engage in episodes of binge eating.
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including cancer, neuro-degenerative diseases, blood and vision disorders and organ regeneration and repair.
› Verified 5 days ago
| Provider Name | Callie Lamay Dpm Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1376269357 PECOS PAC ID: 6901276583 Enrollment ID: O20221222001057 |
News Archive
Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern. Recombinant monoclonal antibody therapeutics (mAbs) represent the largest group of therapeutic proteins the analysis of the glycan pattern is therefore an essential part of the mAb characterization process.
A study by York University researcher Caroline Davis and her colleagues at the Centre for Addiction and Mental Health is the first to demonstrate that variants of the Oxytocin Receptor gene contribute to why some of us overeat or engage in episodes of binge eating.
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including cancer, neuro-degenerative diseases, blood and vision disorders and organ regeneration and repair.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Callie Lamay, DPM 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 | Callie Lamay, DPM 767 Boston Post Rd, Old Saybrook, CT 06475-2127 Ph: (860) 388-2641 |
News Archive
Body Mass Index (BMI), the measure of a person's fat based on their height and weight, may be an effective prognostic tool for specific types of breast cancer, according to research from The University of Texas M. D. Anderson Cancer Center.
The full characterization of biotherapeutics is required by regulatory authorities as properties such as safety, efficacy and the serum half-life of therapeutic proteins can be affected by differences in their glycosylation pattern. Recombinant monoclonal antibody therapeutics (mAbs) represent the largest group of therapeutic proteins the analysis of the glycan pattern is therefore an essential part of the mAb characterization process.
A study by York University researcher Caroline Davis and her colleagues at the Centre for Addiction and Mental Health is the first to demonstrate that variants of the Oxytocin Receptor gene contribute to why some of us overeat or engage in episodes of binge eating.
Novela Neurotech, a medtech company at the forefront of accelerating novel neurological therapies through neural data curation, collaboration and sharing, is excited to join INCF's Industry Advisory Council to help guide efforts at industry and academic collaborations in the neuroscience, data science and neurotech sphere.
An industry-driven consortium has developed a national roadmap designed to chart the path to large-scale manufacturing of cell-based therapeutics for use in a broad range of illnesses including cancer, neuro-degenerative diseases, blood and vision disorders and organ regeneration and repair.
› Verified 5 days ago
John T. Carroll, Dpm Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 455 Boston Post Rd, Unit #8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Callie Lamay Dpm Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Dr. John T Carroll, DPM Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 455 Boston Post Rd Ste 8, Old Saybrook, CT 06475 Phone: 860-510-0502 Fax: 860-510-0551 | |
Saybrook Podiatry Associates, Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 | |
Dr. Kevin M. Wakeham, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 767 Boston Post Rd, Old Saybrook, CT 06475 Phone: 860-388-2641 Fax: 860-395-2928 |